BETHANY BRYANT: Open Payments
NPI 1750610432 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 45 payments from 21 companies in 2025. Trend: 2023 $1,194 · 2024 $895 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $161 |
| GlaxoSmithKline, LLC. | 8 | $149 |
| Abbott Laboratories | 6 | $138 |
| Novo Nordisk Inc | 5 | $95 |
| Astellas Pharma US Inc | 3 | $56 |
| ABBVIE INC. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Corium, LLC | 1 | $28 |
Products named: BREZTRI, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Wegovy, Veozah, CONFIRM RX, SHINGRIX, Auvelity.
Industry payments across TX — which companies pay providers there.
